openPR Logo
Press release

Bronchitis Treatment Market Size, Share, Growth Is Expected To Reach US$ 4,606.3 Mn By 2026 | Credence Research

05-28-2019 09:18 AM CET | Health & Medicine

Press release from: Acute Market Reports

According to the latest report published by Credence Research, Inc. “Bronchitis Treatment Market By Type Of Drug Class (Antitussives/ Expectorants, Bronchodilators, Beta-Adrenergic Agonist, Systemic Corticosteroids, Inhaled Corticosteroids, Phosphodiesterase-4 Inhibitors, Analgesics, Antibiotics) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global Bronchitis Treatment market was valued at USD 3,345.8 Mn in 2017, and is expected to reach USD 4,606.3 Mn by 2026, expanding at a CAGR of 4.9% from 2018 to 2026.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59646

Market Insights

Bronchitis is one of the most common respiratory diseases observed in developed as well as developing countries. Chronic bronchitis is life-threatening most of the times and the Centers for Disease Control and Prevention recorded that 8.6 million people were diagnosed with chronic bronchitis in year 2016 in the U.S with 0.2% of mortality. However, as the U.S is more developed country mortality rate is low but in developing and under developed countries the mortality rate is in range of 3% – 4%. Bronchitis is triggered due to several factors common cold & flu, and other bacterial infections which leads to airway obstruction due to inflammation of bronchial walls. A patient suffering with acute bronchitis takes 1 to 2 weeks to recover while in case of chronic bronchitis it takes 2 to 3 months. However, overall drug pipeline of bronchitis treatment is strong as there are several combination therapies present that provide target-specific performance.

In 2017, bronchodilators was identified as the largest growing segment in bronchitis treatment market due to key factors such as rising prevalence related to bronchitis, and increasing awareness campaigns related to chronic bronchitis, & other bacterial infections in developed & developing countries. The awareness activities carried out in developing and under developed countries have helped to increase the diagnosis rate in last couple of years. Bronchodilators are always the first-line drugs for treatment of bronchitis as the clearing airway obstruction is the most important thing in chronic bronchitis to ease the breathing of patient.

North America was observed as the largest bronchitis treatment market due to rising prevalence coupled with high prevalence of bronchitis, and increasing trend of smoking in young generation have assisted the slight rise in the prevalence rate, developed & accessible diagnostic technologies. According to Pharmaprix, about 1 in 20 people suffers with chronic bronchitis in the North America. In addition to this, North America bronchitis market is also growing due to ongoing development in research of bronchitis treatment drug pipeline.

Market Competition Assessment:

The bronchitis treatment market is growing at steadily and major companies operating in this market are developing treatments that are safe and target-specific. The major companies available in the global market are AstraZeneca Plc, DBV Technologies SA, F. Hoffmann-La Roche Ltd., Han Wha Pharma Co. Ltd., and Mucosis BV among others.

Do Inquiry before buying research report: https://www.credenceresearch.com/inquiry-before-buying/59646

Key Market Movements:

• Rising awareness and prevalence related to bronchitis treatment & diagnosis expected to assist the market growth
• Incessant growth in research & development of bronchitis treatment will assist the growth in demand for safe & efficient treatment options
• Mounting diagnosis rate related to developing countries will increase the demand for bronchitis treatment market
• Strong drug pipeline expected to increase the CAGR of the overall market in the near future

By Type of Drug Class (2016–2026; US$ Mn)

• Antitussives/expectorants
• Bronchodilators
• Beta-adrenergic agonist
• Systemic corticosteroids
• Inhaled corticosteroids
• Phosphodiesterase-4 inhibitors
• Analgesics
• Antibiotics

By Pipeline Analysis (Till 2026; US$ Mn)

• Phase III
o Cyclosporine
o Combination Product: Extracorporeal Photopheresis (ECP)

By Geography Segment (Till 2026; US$ Mn)

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

Browse the full report Bronchitis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/bronchitis-treatment-market

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
Toll-Free (US/CANADA) Ph.: +1-800-361-8290
E-mail: sales@credenceresearch.com
Website: http://www.credenceresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchitis Treatment Market Size, Share, Growth Is Expected To Reach US$ 4,606.3 Mn By 2026 | Credence Research here

News-ID: 1755177 • Views: 153

More Releases from Acute Market Reports

5.2% CAGR to take Cervical Cancer Treatment Market to USD 10.6 bn by 2025
The latest market report published by Credence Research, Inc. “Global Cervical Cancer Treatment Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global cervical cancer treatment market is expected to expand at a CAGR of 5.2% from 2018 to 2026. Market Insights According to the latest research citings of World Health Organization (WHO) in 2018, approximately 570,000 new cases if cervical cancer were reported which eventually represents 6.6% of all
Floating Solar Panels Market: Global Industry Share, Market Trends and Forecast …
According to a new market report published by Credence Research Global Floating Solar Panels Market- Growth, Future Prospects & Competitive Analysis, 2016 - 2023, the Global Floating Solar Panels Market is expected to reach US$ 842.0 Mn by 2023, expanding at a CAGR of 65.1% during the forecast period 2016 to 2023. Browse the full Global Floating Solar Panels Market by Product Type, Location and Geography - Growth, Future Prospects &
Molecular Diagnostics Market: Global Market Share, Size, Industry Approaches, St …
Molecular Diagnostics Market - Market Growth, Future Prospects, Competitive Analysis, 2017 - 2025, the global molecular diagnostics market was valued at US$ 6,077.9 Mn in 2016, and is expected to reach US$ 12,358.6 Mn by 2025 expanding at a CAGR of 7.8 % from 2017 to 2025. View Full Report with TOC @ http://www.acutemarketreports.com/report/molecular-diagnostics-market Market Insights Molecular diagnostics has undergone tremendous technological advancement due to the growing need for personalized medication, rapid diagnosis
Diabetic Footwear Market: Global Market Share, Size, Industry Approaches, Strate …
Diabetic Footwear Market, By Distribution Channels, End Use and Geography - Growth, Future Prospects and Competitive Analysis, 2017 - 2025, the global diabetic footwear market was valued at US$ 4,971.25 Mn in 2016, and is expected to reach US$ 9,495.01 Mn by 2025, expanding at a CAGR of 8.0% from 2017 to 2025. View Full Report with TOC @ http://www.acutemarketreports.com/report/diabetic-footwear-market Market Insights Diabetic footwear which are also referred as therapeutic shoes are shoes

All 5 Releases


More Releases for Bronchitis

Bronchitis Treatment Market: Rising Morbidity & Mortality Rate Leads to Dominanc …
Cough has been one of the most common illness-related reason for ambulatory visits in the United States. As the cough linked with bronchitis is so troublesome and slow to resolve, patients seek treatment. The use of biomarkers in identifying patients who might reap benefit from antibiotics is popular. However, the American Academy of Pediatrics cautions against the use of use of antibiotics for apparent viral respiratory illness, including pharyngitis, bronchitis
Bronchitis Treatment Market with Worldwide Industry Analysis to 2026
The chronic bronchitis is defined as the inflammation of the bronchi that lasts for more than 3 months for consecutive 2 years. The bronchi are the tubes which carry air in to the lungs. The major symptom of bronchitis is persistent cough associated with mucus expectoration, headache, nasal congestion, sore throat and fatigue. Risk factors for bronchitis include irritants, chemicals, air pollution and smoke. There are mainly two types of
Trends in the Bronchitis Treatment Market 2016-2026
The chronic bronchitis is defined as the inflammation of the bronchi that lasts for more than 3 months for consecutive 2 years. The bronchi are the tubes which carry air in to the lungs. The major symptom of bronchitis is persistent cough associated with mucus expectoration, headache, nasal congestion, sore throat and fatigue. Risk factors for bronchitis include irritants, chemicals, air pollution and smoke. There are mainly two types of
Global Bronchitis Market Research Report - Pipeline Review, H2 2017
"The Latest Research Report Bronchitis-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Bronchitis Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchitis-Pipeline Review, H2 2017, provides an overview of the Bronchitis (Respiratory) pipeline landscape. Bronchitis is an inflammation of the lining of bronchial tubes, which carry air to and from lungs. Symptoms include cough that produces
Chronic Bronchitis - Pipeline Research and Markets Insight, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Chronic Bronchitis - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Chronic Bronchitis. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265427 The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Chronic Bronchitis by development stage, therapy
Bronchitis Treatment Market Segments And Key Trends 2016-2026
The chronic bronchitis is defined as the inflammation of the bronchi that lasts for more than 3 months for consecutive 2 years. The bronchi are the tubes which carry air in to the lungs. The major symptom of bronchitis is persistent cough associated with mucus expectoration, headache, nasal congestion, sore throat and fatigue. Risk factors for bronchitis include irritants, chemicals, air pollution and smoke. There are mainly two types of